News and commentary from the world of gastroenterology and hepatology ...

While conversations about cancer risk often center on genetics and lifestyle choices, emerging research highlights a more insidious threat lurking in millions of American stomachs. Helicobacter pylori ...

August 1, 2008 — A Japanese study of patients with early gastric cancer shows that eradicating the bacteria Helicobacter pylori after surgery greatly reduces the risk of gastric cancer developing ...

Each unit of cost invested in Helicobacter pylori screening can generate approximately a fivefold return in gastric cancer ...

Infection with Helicobacter pylori is one of the top risk factors for stomach cancer — but only a small proportion of individuals who carry the bacterium go on to develop cancer. Identifying who is ...

New research published in the journal Gastroenterology offers insight on gastric cancer and the presence of the common bacteria known as H. pylori (Helicobacter pylori). Although previous studies have ...

A history of Helicobacter pylori infection had a modest but statistically significant association with an increased risk of colorectal cancer (CRC), including fatal CRC, a large retrospective analysis ...

A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have ...

Scientists have recently identified new strategies used by Helicobacter pylori bacteria to infect cells. By specifically targeting mitochondria these bacteria, despite being extracellular, can ...

Gastric cancer is one of the five most fatal types of cancer. According to the statistics of the World Health Organization about 750,000 patients die each year after developing the disease. The main ...

Helicobacter pylori is a spiral-shaped, gram-negative bacterium that colonises the human stomach and is recognised as a major risk factor for the development of gastric adenocarcinoma. Paradoxically, ...

An invitation to undergo screening for Helicobacter pylori stool antigen did not reduce rates of gastric cancer incidence or mortality, according to results from a Taiwanese randomized trial. H.